Long term outcomes of laparoscopic sacro/colpo-hysteropexy with and without rectopexy for the treatment of prolapse.


Journal

International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 13 03 2021
accepted: 19 05 2021
pubmed: 15 6 2021
medline: 1 4 2022
entrez: 14 6 2021
Statut: ppublish

Résumé

Laparoscopic sacrohysteropexy (LSH), sacrocolpopexy (LSC) and ventral rectopexy (LVR) with mesh are advocated for surgical treatment of pelvic and rectal prolapse. Our study aims at showing the feasibility of concomitant laparoscopic prolapse repair by comparing perioperative and long-term outcomes of LSH or LSC with and without LVR. This is a retrospective study carried out on 348 women operated on between July 2009 and July 2019. Patients were divided into four groups: (1) LSH only, (2) LSC only, (3) LSH + LVR and (4) LSC + LVR. POP-Q scores and satisfaction questionnaires were recorded at baseline and then annually. Outcomes were defined as subjective failure (vaginal/rectal prolapse symptoms), objective failure (prolapse to/beyond the hymen, full thickness rectal prolapse) or retreatment for prolapse. Complications were collected and graded according to the Clavien-Dindo classification. Three hundred forty-eight women underwent laparoscopic repair for pelvic and rectal prolapse (219, 44, 66 and 19 in group 1, 2, 3 and 4, respectively). Median follow-up was 24 (4-174) months. Success rate for both rectal and pelvic prolapse was 90.2%. Recurrence rates were not significantly different between the groups (12.3%, 6.8%, 9.1% and 10.5% for groups 1, 2, 3 and 4, respectively). Significant improvement was noticed in satisfaction questionnaires in all groups. There was no difference in perioperative and late complications. The combined laparoscopic procedure appears to be safe and efficient in treating pelvic and rectal prolapse. Appropriate patient selection and available surgical expertise should determine whether to perform these procedures combined or separately.

Identifiants

pubmed: 34125240
doi: 10.1007/s00192-021-04868-x
pii: 10.1007/s00192-021-04868-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

343-350

Informations de copyright

© 2021. The International Urogynecological Association.

Références

Cooper J, Annappa M, Dracocardos D, Cooper W, Muller S, Mallen C. Prevalence of genital prolapse symptoms in primary care: a cross-sectional survey. Int Urogynecol J. 2015;26:505–10.
pubmed: 25381004
Lim M, Sagar PM, Gonsalves S, Thekkinkattil D, Landon C. Surgical management of pelvic organ prolapse in females: functional outcome of mesh sacrocolpopexy and rectopexy as a combined procedure. Dis Colon Rectum. 2007;50(9):1412–21.
pubmed: 17566828
Jallad K, Gurland B. Multidisciplinary approach to the treatment of concomitant rectal and vaginal prolapse. Clin Colon Rectal Surg. 2016;29(2):101–5.
pubmed: 27247534 pmcid: 4882172
Ganatra AM, Rozet F, Sanchez-Salas R, Barret E, Galiano M, Cathelineau X, et al. The current status of laparoscopic sacrocolpopexy: a review. Eur Urol. 2009;55(5):1089–105.
pubmed: 19201521
Meriwether KV, Antosh DD, Olivera CK, Kim-Fine S, Balk EM, Murphy M, et al. Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines. Am J Obstet Gynecol. 2018;219(2):129–146.e2.
pubmed: 29353031
Gluck O, Blaganje M, Veit-Rubin N, Phillips C, Deprest J, O’reilly B, et al. Laparoscopic sacrocolpopexy: a comprehensive literature review on current practice. Eur J Obstet Gynecol Reprod Biol. 2019;245:94–101.
pubmed: 31891897
D’Hoore A, Penninckx F. Laparoscopic ventral recto (colpo)pexy for rectal prolapse: surgical technique and outcome for 109 patients. Surg Endosc. 2006;20(12):1919–23.
pubmed: 17031741
Thomas TN, Davidson ERW, Lampert EJ, Paraiso MFR, Ferrando CA. Long-term pelvic organ prolapse recurrence and mesh exposure following sacrocolpopexy. Int Urogynecol J. 2020;31:1763–70.
pubmed: 32253489
Mercer-Jones MA, D’Hoore A, Dixon AR, Lehur P, Lindsey I, Mellgren A, et al. Consensus on ventral rectopexy: report of a panel of experts. Color Dis. 2014;16(2):82–8.
Mackenzie H, Dixon AR. Proficiency gain curve and predictors of outcome for laparoscopic ventral mesh rectopexy. Surg (United States). 2014;156(1):158–67.
Franceschilli L, Varvaras D, Capuano I, Ciangola CI, Giorgi F, Boehm G, et al. Laparoscopic ventral rectopexy using biologic mesh for the treatment of obstructed defaecation syndrome and/or faecal incontinence in patients with internal rectal prolapse: a critical appraisal of the first 100 cases. Tech Coloproctol. 2015;19(4):209–19.
pubmed: 25577276
van Iersel JJ, Paulides TJC, Verheijen PM, Lumley JW, Broeders IAMJ, Consten ECJ. Current status of laparoscopic and robotic ventral mesh rectopexy for external and internal rectal prolapse. World J Gastroenterol. 2016;22(21):4977.
pubmed: 27275090 pmcid: 4886373
Formijne Jonkers HA, Poierrié N, Draaisma WA, Broeders IAMJ, Consten ECJ. Laparoscopic ventral rectopexy for rectal prolapse and symptomatic rectocele: an analysis of 245 consecutive patients. Color Dis. 2013;15(6):695–9.
van den Esschert JW, van Geloven AAW, Vermulst N, Groenedijk A, de Wit LT, Gerhards MF, et al. Laparoscopic ventral rectopexy for obstructed defecation syndrome. Surg Endosc. 2008;22(12):2728–32.
pubmed: 18320283
Gluck O, Blaganje M, Deval B. How I do … laparoscopic ventral rectopexy using a synthetic mesh. Gynecol Obstet Fertil Senol. 2019;47(10):753–6.
pubmed: 31494314
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.
pubmed: 15273542 pmcid: 15273542
Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36(1):77–97.
pubmed: 8416784
Wren PA, Janz NK, Brubaker L, Fitzgerald MP, Weber AM, LaPorte FB, et al. Reliability of health-related quality-of-life measures 1 year after surgical procedures for pelvic floor disorders. Am J Obstet Gynecol. 2005;192(3):780–8.
pubmed: 15746672
Rogers RG, Coates KW, Kammerer-Doak D, Khalsa S, Qualls C. A short form of the pelvic organ prolapse/urinary incontinence sexual questionnaire (PISQ-12). Int Urogynecol J Pelvic Floor Dysfunct. 2003;14(3):164–8.
Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193(1):103–13.
pubmed: 16021067
Miklos JR, Chinthakanan O, Moore RD, Mitchell GK, Favors S, Karp DR, et al. The IUGA/ICS classification of synthetic mesh complications in female pelvic floor reconstructive surgery: a multicenter study. Int Urogynecol J. 2016;27(6):933–8.
pubmed: 26690360
Jallad K, Ridgeway B, Paraiso MFR, Gurland B, Unger CA. Long-term outcomes after ventral rectopexy with sacrocolpo- or hysteropexy for the treatment of concurrent rectal and pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2018;24(5):336–40.
pubmed: 28657998
Watadani Y, Vogler SA, Warshaw JS, Sueda T, Lowry AC, Madoff RD, et al. Sacrocolpopexy with rectopexy for pelvic floor prolapse improves bowel function and quality of life. Dis Colon Rectum. 2013;56(12):1415–22.
pubmed: 24201397
Thibault F, Costa P, Thanigasalam R, Seni G, Brouzyine M, Cayzergues L, et al. Impact of laparoscopic sacrocolpopexy on symptoms, health-related quality of life and sexuality: a medium-term analysis. BJU Int. 2013;112(8):1143–9.
pubmed: 24007194
Şükür YE, Dökmeci F, Çetinkaya ŞE, Seval MM. Comparison of patient reported outcomes, pelvic floor function and recurrence after laparoscopic sacrohysteropexy versus vaginal hysterectomy with McCall suspension for advanced uterine prolapse. Eur J Obstet Gynecol Reprod Biol. 2020;247:127–31.
pubmed: 32092668
Unger CA, Paraiso MFR, Jelovsek JE, Barber MD, Ridgeway B. Perioperative adverse events after minimally invasive abdominal sacrocolpopexy. Am J Obstet Gynecol. 2014;211(5):547.e1–8.
van Iersel JJ, de Witte CJ, Verheijen PM, Broeders IAMJ, Lenters E, Consten ECJ, et al. Robot-assisted Sacrocolporectopexy for multicompartment prolapse of the pelvic floor: a prospective cohort study evaluating functional and sexual outcome. Dis Colon Rectum. 2016;59(10):968–74.
pubmed: 27602928
Qu D-C, Chen H-B, Yang M-M, Zhou H-G. Management of lumbar spondylodiscitis developing after laparoscopic sacrohysteropexy with a mesh: a case report and review of the literature. Medicine (Baltimore). 2019;98(49):e18252.
Brito LG, Giraudet G, Lucot J-P, Cosson M. Spondylodiscitis after sacrocolpopexy. Eur J obstet Gynecol Reproduct Biol. 2015;187:72.
Illiano E, Giannitsas K, Li Marzi V, Natale F, Manicini V, Costantini E. No treatment required for asymptomatic vaginal mesh exposure. Urol Int. 2019;103(2):223–7.
pubmed: 31230054

Auteurs

Ehud Grinstein (E)

Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel.
affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yara Abdelkhalek (Y)

Department of Obstetrics and Gynecology. Hôtel-Dieu de France University Hospital, St Joseph University, Beirut, Lebanon. yaraabdelkhalek1@gmail.com.
, Paris, France. yaraabdelkhalek1@gmail.com.

Nikolaus Veit-Rubin (N)

Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.

Ohad Gluck (O)

Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel.
affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Bruno Deval (B)

Department of Functional Pelvic Surgery & Oncology, Geoffroy Saint-Hilaire, Ramsay Santé, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH